Silver Oak Securities’s ResMed RMD Stock Holding History

Silver Oak Securities’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Sell	6,960 -380	-5%	-$78.8K	0.08%	227
2026 Q1	$1.65M	Buy	7,340 +457	+7%	+$114K	0.12%	175
2025 Q4	$1.67M	Buy	6,883 +199	+3%	+$50.9K	0.11%	184
2025 Q3	$1.83M	Buy	6,684 +1,453	+28%	+$397K	0.14%	155
2025 Q2	$1.35M	Buy	5,231 +364	+7%	+$86.8K	0.11%	195
2025 Q1	$1.07M	Sell	4,867 -675	-12%	-$158K	0.1%	223
2024 Q4	$1.27M	Buy	5,542 +709	+15%	+$171K	0.12%	180
2024 Q3	$1.16M	Buy	4,833 +4,748	+5,586%	+$1.06M	0.12%	181
2024 Q2	$16.3K	Buy	+85	New	+$17.2K	﹤0.01%	467

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Silver Oak Securities's RMD Position: Q2 2026 in Review

Silver Oak Securities reduced its ResMed (RMD) stake by 5.2% in Q2 2026, selling an estimated $78.8K and leaving 6,960 shares worth $1.36M. The position accounts for 0.08% of the portfolio, ranked #227.

Silver Oak Securities first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.83M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Silver Oak Securities held 6,960 shares of ResMed worth $1.36M as of Q2 2026.
Silver Oak Securities sold 380 ResMed shares in Q2 2026, an estimated $78.8K.
ResMed made up 0.08% of Silver Oak Securities's portfolio in Q2 2026, its #227 holding.
Silver Oak Securities first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
Silver Oak Securities's ResMed position peaked at $1.83M in Q3 2025.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Silver Oak Securities's 13F filing for Q2 2026, filed 7 Aug 2026.